S2k Guidelines for Cutaneous Basal Cell Carcinoma – Part 2: Treatment, Prevention and Follow-up

Berenice M. Lang; Panagiotis Balermpas; Andrea Bauer; Andreas Blum; G. Felix Brölsch; Thomas Dirschka; Markus Follmann; Jorge Frank; Bernhard Frerich; Klaus Fritz; Axel Hauschild; Ludwig M. Heindl; Hans Peter Howaldt; Stephan Ihrler; Vinodh Kakkassery; Bernhard Klumpp; Albrecht Krause-Bergmann; Christoph Löser; Markus Meissner; Michael M. Sachse; Max Schlaak; Michael P. Schön; Lutz Tischendorf; Michael Tronnier; Dirk Vordermark; Julia Welzel; Michael Weichenthal; Susanne Wiegand; Roland Kaufmann; Stephan Grabbe

doi:10.1111/ddg.13755

S2k Guidelines for Cutaneous Basal Cell Carcinoma – Part 2: Treatment, Prevention and Follow-up

Berenice M. Lang, Panagiotis Balermpas, Andrea Bauer, Andreas Blum, G. Felix Brölsch, Thomas Dirschka, Markus Follmann, Jorge Frank, Bernhard Frerich, Klaus Fritz, Axel Hauschild, Ludwig M. Heindl, Hans Peter Howaldt, Stephan Ihrler, Vinodh Kakkassery, Bernhard Klumpp, Albrecht Krause-Bergmann, Christoph Löser, Markus Meissner, Michael M. SachseMax Schlaak, Michael P. Schön, Lutz Tischendorf, Michael Tronnier, Dirk Vordermark, Julia Welzel, Michael Weichenthal, Susanne Wiegand, Roland Kaufmann, Stephan Grabbe^*

^*Corresponding author for this work

Clinic of Ophtalmology

Abstract

Basal cell carcinoma (BCC) is the most common malignant tumor among fair-skinned individuals, and its incidence had been steadily rising in the past decades. In order to maintain the highest quality of patient care possible, the German S2k guidelines were updated following a systematic literature search and with the participation of all professional societies and associations involved in the management of the disease. Part 2 addresses issues such as proper risk stratification, the various therapeutic approaches, and prevention as well as follow-up of patients with basal cell carcinoma.

Original language	English
Journal	JDDG - Journal of the German Society of Dermatology
Volume	17
Issue number	2
Pages (from-to)	214-230
Number of pages	17
ISSN	1610-0379
DOIs	https://doi.org/10.1111/ddg.13755
Publication status	Published - 01.02.2019

Research Areas and Centers

Research Area: Luebeck Integrated Oncology Network (LION)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/ddg.13755

Cite this

Lang, B. M., Balermpas, P., Bauer, A., Blum, A., Brölsch, G. F., Dirschka, T., Follmann, M., Frank, J., Frerich, B., Fritz, K., Hauschild, A., Heindl, L. M., Howaldt, H. P., Ihrler, S., Kakkassery, V., Klumpp, B., Krause-Bergmann, A., Löser, C., Meissner, M., ... Grabbe, S. (2019). S2k Guidelines for Cutaneous Basal Cell Carcinoma – Part 2: Treatment, Prevention and Follow-up. JDDG - Journal of the German Society of Dermatology, 17(2), 214-230. https://doi.org/10.1111/ddg.13755

@article{005943f82cd640459f6aaaebae487a9a,

title = "S2k Guidelines for Cutaneous Basal Cell Carcinoma – Part 2: Treatment, Prevention and Follow-up",

abstract = "Basal cell carcinoma (BCC) is the most common malignant tumor among fair-skinned individuals, and its incidence had been steadily rising in the past decades. In order to maintain the highest quality of patient care possible, the German S2k guidelines were updated following a systematic literature search and with the participation of all professional societies and associations involved in the management of the disease. Part 2 addresses issues such as proper risk stratification, the various therapeutic approaches, and prevention as well as follow-up of patients with basal cell carcinoma.",

author = "Lang, {Berenice M.} and Panagiotis Balermpas and Andrea Bauer and Andreas Blum and Br{\"o}lsch, {G. Felix} and Thomas Dirschka and Markus Follmann and Jorge Frank and Bernhard Frerich and Klaus Fritz and Axel Hauschild and Heindl, {Ludwig M.} and Howaldt, {Hans Peter} and Stephan Ihrler and Vinodh Kakkassery and Bernhard Klumpp and Albrecht Krause-Bergmann and Christoph L{\"o}ser and Markus Meissner and Sachse, {Michael M.} and Max Schlaak and Sch{\"o}n, {Michael P.} and Lutz Tischendorf and Michael Tronnier and Dirk Vordermark and Julia Welzel and Michael Weichenthal and Susanne Wiegand and Roland Kaufmann and Stephan Grabbe",

note = "{\textcopyright} 2019 The Authors | Journal compilation {\textcopyright} Blackwell Verlag GmbH, Berlin.",

year = "2019",

month = feb,

day = "1",

doi = "10.1111/ddg.13755",

language = "English",

volume = "17",

pages = "214--230",

journal = "JDDG - Journal of the German Society of Dermatology",

issn = "1610-0379",

number = "2",

}

Lang, BM, Balermpas, P, Bauer, A, Blum, A, Brölsch, GF, Dirschka, T, Follmann, M, Frank, J, Frerich, B, Fritz, K, Hauschild, A, Heindl, LM, Howaldt, HP, Ihrler, S, Kakkassery, V, Klumpp, B, Krause-Bergmann, A, Löser, C, Meissner, M, Sachse, MM, Schlaak, M, Schön, MP, Tischendorf, L, Tronnier, M, Vordermark, D, Welzel, J, Weichenthal, M, Wiegand, S, Kaufmann, R & Grabbe, S 2019, 'S2k Guidelines for Cutaneous Basal Cell Carcinoma – Part 2: Treatment, Prevention and Follow-up', JDDG - Journal of the German Society of Dermatology, vol. 17, no. 2, pp. 214-230. https://doi.org/10.1111/ddg.13755

TY - JOUR

T1 - S2k Guidelines for Cutaneous Basal Cell Carcinoma – Part 2: Treatment, Prevention and Follow-up

AU - Lang, Berenice M.

AU - Balermpas, Panagiotis

AU - Bauer, Andrea

AU - Blum, Andreas

AU - Brölsch, G. Felix

AU - Dirschka, Thomas

AU - Follmann, Markus

AU - Frank, Jorge

AU - Frerich, Bernhard

AU - Fritz, Klaus

AU - Hauschild, Axel

AU - Heindl, Ludwig M.

AU - Howaldt, Hans Peter

AU - Ihrler, Stephan

AU - Kakkassery, Vinodh

AU - Klumpp, Bernhard

AU - Krause-Bergmann, Albrecht

AU - Löser, Christoph

AU - Meissner, Markus

AU - Sachse, Michael M.

AU - Schlaak, Max

AU - Schön, Michael P.

AU - Tischendorf, Lutz

AU - Tronnier, Michael

AU - Vordermark, Dirk

AU - Welzel, Julia

AU - Weichenthal, Michael

AU - Wiegand, Susanne

AU - Kaufmann, Roland

AU - Grabbe, Stephan

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Basal cell carcinoma (BCC) is the most common malignant tumor among fair-skinned individuals, and its incidence had been steadily rising in the past decades. In order to maintain the highest quality of patient care possible, the German S2k guidelines were updated following a systematic literature search and with the participation of all professional societies and associations involved in the management of the disease. Part 2 addresses issues such as proper risk stratification, the various therapeutic approaches, and prevention as well as follow-up of patients with basal cell carcinoma.

AB - Basal cell carcinoma (BCC) is the most common malignant tumor among fair-skinned individuals, and its incidence had been steadily rising in the past decades. In order to maintain the highest quality of patient care possible, the German S2k guidelines were updated following a systematic literature search and with the participation of all professional societies and associations involved in the management of the disease. Part 2 addresses issues such as proper risk stratification, the various therapeutic approaches, and prevention as well as follow-up of patients with basal cell carcinoma.

UR - http://www.scopus.com/inward/record.url?scp=85061609766&partnerID=8YFLogxK

UR - http://www.mendeley.com/research/s2k-guidelines-cutaneous-basal-cell-carcinoma-part-2-treatment-prevention-followup-1

UR - http://www.mendeley.com/research/s2k-guidelines-cutaneous-basal-cell-carcinoma-part-2-treatment-prevention-followup

U2 - 10.1111/ddg.13755

DO - 10.1111/ddg.13755

M3 - Journal articles

C2 - 30762963

AN - SCOPUS:85061609766

SN - 1610-0379

VL - 17

SP - 214

EP - 230

JO - JDDG - Journal of the German Society of Dermatology

JF - JDDG - Journal of the German Society of Dermatology

IS - 2

ER -

S2k Guidelines for Cutaneous Basal Cell Carcinoma – Part 2: Treatment, Prevention and Follow-up

Abstract

Research Areas and Centers

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this